Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review.
Suqi ZhuYahan YuMingqi YangXin LiuMingkai LaiJieren ZhongXiaoguang ZhaoLigong LuYanyan LiuPublished in: Expert review of anticancer therapy (2024)
The combination of HAIC with the FOLFOX regimen can help prevent the low intratumoral accumulation and high adverse reaction rate caused by the FOLFOX alone, holding significant potential in the comprehensive treatment of future HCC patients.